{"id":129,"date":"2022-09-13T11:53:39","date_gmt":"2022-09-13T11:53:39","guid":{"rendered":"https:\/\/admedsol1stg.wpenginepowered.com\/?page_id=129"},"modified":"2026-03-24T11:15:46","modified_gmt":"2026-03-24T11:15:46","slug":"aim-rule-26-information","status":"publish","type":"page","link":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/","title":{"rendered":"Aim Rule 26 Information"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; module_class=&#8221;ams-angle-header white&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Aim-Rule-26.jpg&#8221; background_size=&#8221;custom&#8221; background_image_width=&#8221;50%&#8221; background_position=&#8221;center_right&#8221; custom_padding_tablet=&#8221;6rem||4rem||false|false&#8221; custom_padding_phone=&#8221;5rem||4rem||false|false&#8221; hover_enabled=&#8221;0&#8243; background_last_edited=&#8221;on|phone&#8221; use_background_color_gradient_tablet=&#8221;off&#8221; use_background_color_gradient_phone=&#8221;on&#8221; background_color_gradient_direction_phone=&#8221;135deg&#8221; background_color_gradient_stops_phone=&#8221;#461a46 0%|rgba(119,43,120,0.75) 100%&#8221; background_color_gradient_overlays_image_tablet=&#8221;on&#8221; background_size_tablet=&#8221;cover&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; custom_css_before_last_edited=&#8221;off|phone&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_row _builder_version=&#8221;4.22.2&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;0rem||3.5rem||false|false&#8221; custom_margin_tablet=&#8221;||0rem||false|false&#8221; custom_margin_phone=&#8221;||0rem||false|false&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"ams-h5 ams-white ams-bold\"><!-- [et_pb_line_break_holder] -->  Shareholder Information<!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h1 class=\"ams-h3 ams-white ams-light\"><!-- [et_pb_line_break_holder] -->  AIM Rule 26 Information<!-- [et_pb_line_break_holder] --><\/h1>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<div class=\"ams-btn ams-primary-btn white ams-mt-32\"><!-- [et_pb_line_break_holder] -->  <a href=\"\/contact\/\"><!-- [et_pb_line_break_holder] -->    Contact Us<!-- [et_pb_line_break_holder] -->    <i class=\"fa-regular fa-angle-right\"><\/i><\/a><!-- [et_pb_line_break_holder] --><\/div>\n<p>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; disabled_on=&#8221;on|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(255,255,255,0.9)&#8221; custom_margin=&#8221;-3.5rem||0px||false|false&#8221; custom_padding=&#8221;1rem||1rem||false|false&#8221; custom_padding_tablet=&#8221;1rem||1rem||true|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_sidebar area=&#8221;et_pb_widget_area_1&#8243; module_id=&#8221;breadcrumbs&#8221; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<pee class=\"ams-bold\">The information below is disclosed in accordance with AIM Rule 26<\/pee>[\/et_pb_code][et_pb_code _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div id=\"aim-26-grid\" class=\"ams-grid ams-gap-32\"><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">30 September 2025<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Last Update<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">AMS<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Stock Code<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\"> 219, 380, 303<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Issued Share Capital<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">31 December<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Accounting Year End<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">England and Wales<!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Country of registration<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">UK, Europe and the US<!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Main Country of Operation<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">30 April 2002<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Date Listed<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">SETS<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Trading Platform<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">86.25%<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Free Float<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">2867684<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Company Number<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] -->  <!-- Tile --><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-grid-col-12 ams-grid-col-lg-4\"><!-- [et_pb_line_break_holder] -->  <\/p>\n<div class=\"ams-h5 ams-bg-purple-4 ams-white ams-p-24 ams-br-16\">AIM Market of the London Stock Exchange<\/div>\n<p><!-- [et_pb_line_break_holder] -->    <pee class=\"ams-bold ams-mt-16\">Exchange<\/pee><!-- [et_pb_line_break_holder] -->  <\/div>\n<p><!-- [et_pb_line_break_holder] -->  <!-- [et_pb_line_break_holder] --><\/div>\n<p>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;6rem||0rem||false|false&#8221; custom_padding=&#8221;0px||2rem||false|false&#8221; custom_css_main_element=&#8221;border-bottom: 2px solid var(&#8211;ams-interface-1)&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.25.2&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||0px||false|false&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<pee class=\"ams-mb-16\">AMS is subject to the UK City Code on Takeovers and Mergers.<\/pee><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] --><pee class=\"ams-mb-16\">The free float percentage consists of the holdings of the Directors\u2019 beneficial holdings, the holdings of the AMS Trustee Company in respect of the Company\u2019s Share Incentive Plan (SIP), and the Company\u2019s significant shareholders.<\/pee><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] --><pee>To find out further information as required by AIM Rule 26 click on the links below.<\/pee>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;2rem||0rem||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.24.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4 class=\"ams-bold ams-mb-24\">Company Information<\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee><a href=\"\/who-we-are\/\" class=\"ams-text-link\">Who We Are<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/corporate-governance\/board-of-directors\/\" class=\"ams-text-link\">Board of Directors<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/corporate-governance\/\" class=\"ams-text-link\">Corporate Governance<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/shareholder-information\/advisors\/\" class=\"ams-text-link\">NOMAD and Advisor Information<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/corporate-governance\/board-committees\" class=\"ams-text-link\">Terms of Reference &#038; Committees<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/corporate-governance\/directors-responsibilities\/\" class=\"ams-text-link\">Board of Directors Responsibilities<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/contact\/\" class=\"ams-text-link\">Registered Offices<\/a><\/pee>[\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4 class=\"ams-bold ams-mb-24\">Documentations and Announcements<\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee><a href=\"\/wp-content\/uploads\/2023\/06\/2006-Articles-of-Association.pdf\" target=\"blank\" class=\"ams-text-link\" rel=\"noopener\">Articles of Association (Constitutional Documents)<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/financial-reports-results\/annual-interim-reports\/\" class=\"ams-text-link\">Annual and Interim Reports<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/shareholder-information\/company-documents\/\" class=\"ams-text-link\">Prospectuses, Shareholder Circulars and Admission Document<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee><a href=\"\/regulatory-news-announcements-rns\/\" class=\"ams-text-link\">Regulatory News Announcements<\/a><\/pee>[\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4 class=\"ams-bold ams-mb-24\">Securities Information<\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee><a href=\"\/investor-relations\/shareholder-information\/shareholder-analysis\/\" class=\"ams-text-link\">Shareholder Analysis<\/a><\/pee><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!-- [et_pb_line_break_holder] --><pee>Lock-In Arrangements &#038; Transfer Restrictions \u2013 There are no restrictions on the transfer of securities.<\/pee>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The information below is disclosed in accordance with AIM Rule 26<\/p>\n","protected":false},"author":4,"featured_media":815,"parent":127,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"page_collections":[],"class_list":["post-129","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Aim Rule 26 Information - Advanced Medical Solutions<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aim Rule 26 Information\" \/>\n<meta property=\"og:description\" content=\"The information below is disclosed in accordance with AIM Rule 26\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/\" \/>\n<meta property=\"og:site_name\" content=\"Advanced Medical Solutions\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T11:15:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Aim-Rule-26.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/\",\"url\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/\",\"name\":\"Aim Rule 26 Information - Advanced Medical Solutions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Aim-Rule-26.jpg\",\"datePublished\":\"2022-09-13T11:53:39+00:00\",\"dateModified\":\"2026-03-24T11:15:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Aim-Rule-26.jpg\",\"contentUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Aim-Rule-26.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/aim-rule-26-information\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admedsol.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor Relations\",\"item\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Shareholder Information\",\"item\":\"https:\\\/\\\/admedsol.com\\\/investor-relations\\\/shareholder-information\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Aim Rule 26 Information\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#website\",\"url\":\"https:\\\/\\\/admedsol.com\\\/\",\"name\":\"Advanced Medical Solutions\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admedsol.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#organization\",\"name\":\"Advanced Medical Solutions\",\"url\":\"https:\\\/\\\/admedsol.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admedsol.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"contentUrl\":\"https:\\\/\\\/admedsol.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/ams-logo-on-white.webp\",\"width\":1200,\"height\":845,\"caption\":\"Advanced Medical Solutions\"},\"image\":{\"@id\":\"https:\\\/\\\/admedsol.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/advanced-medical-solutions\\\/\",\"https:\\\/\\\/uk.linkedin.com\\\/showcase\\\/advanced-medical-solutions-surgical\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/showcase\\\/advanced-medical-solutions-woundcare\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Aim Rule 26 Information - Advanced Medical Solutions","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/","og_locale":"en_US","og_type":"article","og_title":"Aim Rule 26 Information","og_description":"The information below is disclosed in accordance with AIM Rule 26","og_url":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/","og_site_name":"Advanced Medical Solutions","article_modified_time":"2026-03-24T11:15:46+00:00","og_image":[{"url":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Aim-Rule-26.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/","url":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/","name":"Aim Rule 26 Information - Advanced Medical Solutions","isPartOf":{"@id":"https:\/\/admedsol.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/#primaryimage"},"image":{"@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/#primaryimage"},"thumbnailUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Aim-Rule-26.jpg","datePublished":"2022-09-13T11:53:39+00:00","dateModified":"2026-03-24T11:15:46+00:00","breadcrumb":{"@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/#primaryimage","url":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Aim-Rule-26.jpg","contentUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2023\/06\/Aim-Rule-26.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/aim-rule-26-information\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admedsol.com\/"},{"@type":"ListItem","position":2,"name":"Investor Relations","item":"https:\/\/admedsol.com\/investor-relations\/"},{"@type":"ListItem","position":3,"name":"Shareholder Information","item":"https:\/\/admedsol.com\/investor-relations\/shareholder-information\/"},{"@type":"ListItem","position":4,"name":"Aim Rule 26 Information"}]},{"@type":"WebSite","@id":"https:\/\/admedsol.com\/#website","url":"https:\/\/admedsol.com\/","name":"Advanced Medical Solutions","description":"","publisher":{"@id":"https:\/\/admedsol.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admedsol.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/admedsol.com\/#organization","name":"Advanced Medical Solutions","url":"https:\/\/admedsol.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admedsol.com\/#\/schema\/logo\/image\/","url":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","contentUrl":"https:\/\/admedsol.com\/wp-content\/uploads\/2024\/01\/ams-logo-on-white.webp","width":1200,"height":845,"caption":"Advanced Medical Solutions"},"image":{"@id":"https:\/\/admedsol.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/advanced-medical-solutions\/","https:\/\/uk.linkedin.com\/showcase\/advanced-medical-solutions-surgical\/","https:\/\/www.linkedin.com\/showcase\/advanced-medical-solutions-woundcare\/"]}]}},"_links":{"self":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/comments?post=129"}],"version-history":[{"count":0,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/129\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/pages\/127"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/media\/815"}],"wp:attachment":[{"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/media?parent=129"}],"wp:term":[{"taxonomy":"page_collections","embeddable":true,"href":"https:\/\/admedsol.com\/wp-json\/wp\/v2\/page_collections?post=129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}